Skip to main content

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 '22

By: Newsfile

Dallas, Texas--(Newsfile Corp. - April 10, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/BPTH_Q422.pdf

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Owning the Breakthrough Technology
  • Ongoing Clinical Trials
  • First Patients Recently Dosed

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/161882_figure1_550.jpg

Click image above to view full announcement.


About Stonegate Capital Partners
Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high-quality investment opportunities.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/161882

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.89
+3.74 (1.86%)
AAPL  264.13
+0.25 (0.09%)
AMD  198.88
-4.20 (-2.07%)
BAC  53.30
+0.56 (1.07%)
GOOG  303.34
+0.52 (0.17%)
META  642.19
+2.90 (0.45%)
MSFT  400.16
+3.30 (0.83%)
NVDA  187.64
+2.67 (1.44%)
ORCL  156.06
+2.09 (1.35%)
TSLA  411.52
+0.89 (0.22%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.